Walleye Capital’s Alamar Biosciences ALMR Stock Holding History

Walleye Capital’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.2M	Buy	+474,885	New	+$14M	0.01%	908

Other funds holding ALMR

Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Walleye Capital's ALMR Position: Q3 2026 in Review

Walleye Capital opened a new position in Alamar Biosciences (ALMR) in Q3 2026: 474,885 shares worth $16.2M. The stake represents 0.01% of the portfolio and ranks #908 among its holdings.

64 funds tracked by Wall St. Rank hold ALMR as of Q3 2026.

Walleye Capital held 474,885 shares of Alamar Biosciences worth $16.2M as of Q3 2026.
Alamar Biosciences was a new Walleye Capital position in Q3 2026.
Alamar Biosciences made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #908 holding.
64 funds tracked by Wall St. Rank held Alamar Biosciences as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.